ClinicalTrials.gg
Status unknownNCT05586685Updated Mar 23, 2023

Effect of Diaphragmatic Release on Upper Crossed Syndrome

An interventional study of effect of diaphragmatic release on upper crossed syndrome in Neck Muscle Issue and Kyphosis, sponsored by Cairo University. Status unknown. Open to participants aged 17 Years to 22 Years. Per ClinicalTrials.gov, last updated 2023-03-23.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
17 Years to 22 Years
Sex
All
01

Study summary

the study aims to investigate the effectiveness of diaphragmatic release on upper crossed syndrome

Read the detailed description

Poor posture typically causes upper cross syndrome, resulting in neck pain. Neck pain is the most common reason for patients to visit healthcare professionals. This syndrome can cause dysfunctional tone in posture and muscular disparity of the head, neck, and shoulder region . Evidence suggests that 6-48% of the upper crossed syndrome population complain of pain in the shoulder girdle and cervicothoracic region.

Many disorders are linked with the upper crossed syndrome, including migraine headaches; chronic headaches; Subacromial impingement; biceps tendinitis; thoracic outlet syndrome; degeneration of the cervical spine; and joint dysfunction at the C1-C2 segment, C4-C5 segment, cervicothoracic joint, and T4-T5 segment.

Upon the available research studies, there is no study conducted to investigate the effect of diaphragmatic release on upper crossed syndrome patients.

02

Conditions studied

  • Neck Muscle Issue
  • Kyphosis

Browse trials for

03

In context

Kyphosis

135 studies on the registry are indexed under Kyphosis; 26 are open to participants now.

This study's planned enrollment of 30 is below the median of 44 across 78 interventional studies indexed under Kyphosis.

Browse Kyphosis studies →

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 22 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ranged from 17 to 22 years .
  • Body Mass Index from 20 to 25 kg/m².
  • All participants have an intensity of neck pain on VAS (4-8) (moderate cases).
  • The subjects were chosen from both sexes.
  • All participants have kyphosis angle ≥42°
  • All participants have mechanical neck pain and FHP (craniovertebral angle CVA \< 49).

Exclusion criteria

Exclusion Criteria:

  • Malignancy
  • Fractures of the cervical spine
  • Cervical radiculopathy or myelopathy
  • Vascular syndromes such as vertebrobasilar insufficiency
  • Rheumatoid arthritis
  • Neck or upper back surgery
  • Taking anticoagulants
  • Local infection
  • Whiplash injury
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    GroupA diaphragmatic release + conventional

    Group A: diaphragmatic release +conventional The patients will be positioned in the supine position. The therapist stood at the head of the patient contact thoracic cage and ask the patient to take inspiration and move laterally then ask the patient to expire. conventional Subjects will form the letter 'Y' with their arms then they will flex their elbows and move into a position of shoulder extension so that their arms will form the letter 'w L to Y Exercise: Subjects will begin with arms abducted to 90° and elbows flexed to 90° Chin tucks: Subjects will length the neck by pushing the chin into the table in an entirely posterior motion stretch the pectoral area from the supine lying position

    Other: effect of diaphragmatic release on upper crossed syndrome

  • Experimental
    Group B: conventional

    Group B: conventional posture correction exercises Subjects will form the letter 'Y' with their arms then they will flex their elbows and move into a position of shoulder extension, so that their arms will form the letter 'w L to Y Exercise: Subjects will begin with arms abducted to 90° and elbows flexed to 90° Chin tucks : Subjects will length the neck by pushing the chin into the table in an entirely posterior motion stretch pectoral area from supine lying position

    Other: effect of diaphragmatic release on upper crossed syndrome

Interventions

  • Othereffect of diaphragmatic release on upper crossed syndrome

    The patients will be positioned in the supine position. The therapist stood at the head of the patient.therapist make manual contact of ribs and ask patient to inspire the move ribs laterally and then expire conventional exercise Subjects will form the letter 'Y' with their arms then they will flex their elbows and move into a position of shoulder extension, so that their arms will form the letter 'w L to Y Exercise: Subjects will begin with arms abducted to 90° and elbows flexed to 90° Chin tucks : Subjects will length the neck by pushing the chin into the table in an entirely posterior motion stretch pectoral area from supine lying position

06

What researchers measure

Primary outcomes

  1. chest expansion with tape measurement

    using tape to measure chest expansion during inspiration and expiration at axillary level and at the level of T10

    Time frame: up to four weeks

Secondary outcomes

  1. pain intensity with pain numerical scale scale

    The subject was instructed to place a vertical mark on the line to indicate his/her pain which zero is no pain and ten being severe pain.

    Time frame: up to four weeks

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05586685
Lead sponsor
Cairo University
Responsible party
Zeinab Mohamed Abd El-Rahem (teaching assistant at basic science department, faculty of physical therapy egyptian chinese university, Cairo University) — Principal investigator
First posted
Oct 19, 2022
Start date
Mar 20, 2023 (estimated)
Primary completion
Apr 20, 2023 (estimated)
Completion
Apr 20, 2023 (estimated)
Last update
Mar 23, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion